JP2025504430A5 - - Google Patents

Info

Publication number
JP2025504430A5
JP2025504430A5 JP2024542129A JP2024542129A JP2025504430A5 JP 2025504430 A5 JP2025504430 A5 JP 2025504430A5 JP 2024542129 A JP2024542129 A JP 2024542129A JP 2024542129 A JP2024542129 A JP 2024542129A JP 2025504430 A5 JP2025504430 A5 JP 2025504430A5
Authority
JP
Japan
Prior art keywords
group
compound
formula
alkyl group
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024542129A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025504430A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2023/050891 external-priority patent/WO2023135305A1/en
Publication of JP2025504430A publication Critical patent/JP2025504430A/ja
Publication of JP2025504430A5 publication Critical patent/JP2025504430A5/ja
Pending legal-status Critical Current

Links

JP2024542129A 2022-01-17 2023-01-16 脂質化合物及びその使用 Pending JP2025504430A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22305043 2022-01-17
EP22305043.6 2022-01-17
PCT/EP2023/050891 WO2023135305A1 (en) 2022-01-17 2023-01-16 Lipidic compounds, and uses thereof

Publications (2)

Publication Number Publication Date
JP2025504430A JP2025504430A (ja) 2025-02-12
JP2025504430A5 true JP2025504430A5 (cg-RX-API-DMAC7.html) 2025-12-16

Family

ID=80445819

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024542129A Pending JP2025504430A (ja) 2022-01-17 2023-01-16 脂質化合物及びその使用

Country Status (8)

Country Link
US (1) US20250114305A1 (cg-RX-API-DMAC7.html)
EP (1) EP4466248A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025504430A (cg-RX-API-DMAC7.html)
KR (1) KR20240136397A (cg-RX-API-DMAC7.html)
CN (1) CN118829624A (cg-RX-API-DMAC7.html)
AU (1) AU2023206629A1 (cg-RX-API-DMAC7.html)
CA (1) CA3248846A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023135305A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4719352A1 (en) 2023-05-31 2026-04-08 Capstan Therapeutics, Inc. Lipid nanoparticle formulations and compositions
CN122514368A (zh) * 2023-10-24 2026-08-04 三养生物制药 用于药物递送的纳米颗粒组合物
WO2025141521A1 (en) 2023-12-29 2025-07-03 Sanofi Lipids having dendritic moieties
WO2026090137A1 (en) 2024-10-22 2026-04-30 Genzyme Corporation Process for inserting targeting ligand into a lipid nanoparticle encapsulating nucleic acid and compositions produced therefrom

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4500707A (en) 1980-02-29 1985-02-19 University Patents, Inc. Nucleosides useful in the preparation of polynucleotides
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US5132418A (en) 1980-02-29 1992-07-21 University Patents, Inc. Process for preparing polynucleotides
US4415732A (en) 1981-03-27 1983-11-15 University Patents, Inc. Phosphoramidite compounds and processes
US4973679A (en) 1981-03-27 1990-11-27 University Patents, Inc. Process for oligonucleo tide synthesis using phosphormidite intermediates
US4668777A (en) 1981-03-27 1987-05-26 University Patents, Inc. Phosphoramidite nucleoside compounds
US4373071A (en) 1981-04-30 1983-02-08 City Of Hope Research Institute Solid-phase synthesis of polynucleotides
US4401796A (en) 1981-04-30 1983-08-30 City Of Hope Research Institute Solid-phase synthesis of polynucleotides
US5153319A (en) 1986-03-31 1992-10-06 University Patents, Inc. Process for preparing polynucleotides
US5047524A (en) 1988-12-21 1991-09-10 Applied Biosystems, Inc. Automated system for polynucleotide synthesis and purification
US5262530A (en) 1988-12-21 1993-11-16 Applied Biosystems, Inc. Automated system for polynucleotide synthesis and purification
US5573726A (en) * 1993-09-22 1996-11-12 Alcon Laboratories, Inc. Use of amidoamines in ophthalmic compositions
US5700642A (en) 1995-05-22 1997-12-23 Sri International Oligonucleotide sizing using immobilized cleavable primers
EP2938604B1 (en) * 2012-12-28 2018-05-30 Nalco Company Beta-amino ester gas hydrate inhibitors
JPWO2014112280A1 (ja) * 2013-01-17 2017-01-19 学校法人日本大学 油性組成物及び増粘又はゲル形成剤
SG10201801428RA (en) 2013-08-21 2018-03-28 Curevac Ag Method for increasing expression of rna-encoded proteins
US10426737B2 (en) * 2013-12-19 2019-10-01 Novartis Ag Lipids and lipid compositions for the delivery of active agents
CA3042015A1 (en) * 2016-10-26 2018-05-03 Modernatx, Inc. Messenger ribonucleic acids for enhancing immune responses and methods of use thereof
US20190314291A1 (en) * 2018-01-30 2019-10-17 Modernatx, Inc. Compositions and methods for delivery of agents to immune cells
CN113631704A (zh) 2018-12-27 2021-11-09 生命编辑制药股份有限公司 可用于基因编辑的多肽及使用方法
WO2020219876A1 (en) * 2019-04-25 2020-10-29 Intellia Therapeutics, Inc. Ionizable amine lipids and lipid nanoparticles
CN115175894B (zh) * 2020-01-09 2024-09-06 盖德治疗有限责任公司 纳米材料

Similar Documents

Publication Publication Date Title
JP2020510072A5 (cg-RX-API-DMAC7.html)
TW202248190A (zh) 脂質化合物、其組合物、其藥物組合物、製備脂質奈米顆粒的方法及其用途
ES2543841T3 (es) El uso de los esteroides pregnano y androstano en la fabricación de una composición farmacéutica para el tratamiento de trastornos del SNC
JP2002503695A (ja) エストロゲン及び抗エストロゲンから成る組合せ製剤
JP2022502451A5 (cg-RX-API-DMAC7.html)
JP2019500430A5 (cg-RX-API-DMAC7.html)
JP2018533573A5 (cg-RX-API-DMAC7.html)
HRP20220156T1 (hr) Spojevi i pripravci za unutarstaničnu isporuku terapeutskih sredstava
WO2017222016A1 (ja) カチオン性脂質
JP2008512446A (ja) グルココルチコイドおよびグルココルチコイド誘導体のリポソーム性組成物
CN117417264B (zh) 氨基脂质化合物、其制备方法和应用
JP2024542001A5 (cg-RX-API-DMAC7.html)
JP2026503201A5 (cg-RX-API-DMAC7.html)
WO2023179497A1 (zh) 一种脂质化合物及基于其的脂质载体、核酸脂质纳米粒组合物和药物制剂
EP1450816A2 (en) Method of treating disorder related to high cholesterol concentration
JP2022523704A5 (cg-RX-API-DMAC7.html)
US7078396B2 (en) Method of treating disorder related to high cholesterol concentration
JP2024543272A5 (cg-RX-API-DMAC7.html)
JP4324343B2 (ja) トリヨードフェニル基及びステロイド残基を有する化合物
WO2025113662A1 (zh) 一种用于递送核酸的脂质纳米颗粒及其制备方法和用途
JP4046691B2 (ja) トリシクロ[5.2.1.0▲2▼▲.▼▲6▼]−デク−9−イルキサントゲネートの純粋な立体異性体の製造方法およびそれからなる医薬品
GB2079285A (en) Diphosphonate derivatives and pharmaceutical compositions containing them
JP2005112783A (ja) ヨードアリール基を有するリンゴ酸ステロイド誘導体
NZ820531A (en) Long-acting spleen-targeting cationic lipid compound comprising benzene ring structure, composition comprising same, and use thereof
RU2024134033A (ru) Способы и композиции для омоложения иммунных клеток и методы лечения с применением омоложенных иммунных клеток